The Lancet Neurology in conversation with
Un podcast de The Lancet Group - Les jeudis
187 Épisodes
-
Giuseppe Citerio on frailty and TBI
Publié: 19/01/2022 -
Alberto Costa on memantine in adolescents and young adults with Down syndrome
Publié: 20/12/2021 -
Olivier Rascol on amantadine for patients with movement disorders
Publié: 17/11/2021 -
Antonio Uccelli on stems cells for MS
Publié: 20/10/2021 -
Priya Palta on blood pressure control and cognitive decline
Publié: 15/09/2021 -
Adam Boxer on tau biomarkers
Publié: 18/08/2021 -
Irene Cortese on the difficulties of designing clinical trials
Publié: 21/07/2021 -
Doug Turnbull on mitochondrial diseases in adults
Publié: 16/06/2021 -
Geert Jan Biessels on predicting post-stroke cognitive impairment
Publié: 19/05/2021 -
Henk-Jan Westeneng on the causal effects of pre-symptomatic lifestyle on ALS
Publié: 21/04/2021 -
Anne MacGregor on menstrual migraine
Publié: 17/03/2021 -
Peter Rothwell on asymptomatic carotid stenosis and stroke
Publié: 17/02/2021 -
Spinal cord injury and degenerative cervical myelopathy
Publié: 20/01/2021 -
Genetic risk factors for sCJD
Publié: 22/12/2020 -
Prednisone in short-term prevention of cluster headache
Publié: 24/11/2020 -
PET imaging of inflammation in neurological and psychiatric disorders
Publié: 21/10/2020 -
Neurological associations of COVID-19
Publié: 04/09/2020 -
Advances in understanding of Rett syndrome
Publié: 31/07/2020 -
Management of Parkinson's disease
Publié: 17/06/2020 -
Optimal time to treat Huntington's Disease
Publié: 26/05/2020
Editors at The Lancet Neurology, in conversation with the journal’s authors, explore their latest research and its impact on people’s health, healthcare, and health policy.A monthly audio companion to the journal, this podcast covers a broad range of topics, from sleep habits to amyloid biomarkers in Alzheimer’s, the diagnosis and classification of optic neuritis to treatment of Creutzfeldt-Jakob disease, and more.